New Zealand markets close in 4 hours 44 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1200-0.0700 (-3.20%)
At close: 04:00PM EST
2.1200 0.00 (0.00%)
After hours: 05:56PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
156,088
164,522
143,006
95,388
Cost of revenue
39,913
41,305
34,686
22,074
Gross profit
116,175
123,217
108,320
73,314
Operating expenses
Research development
206,970
257,707
292,586
231,347
Selling general and administrative
135,813
163,894
182,769
175,781
Total operating expenses
354,213
425,405
485,066
407,128
Operating income or loss
-238,038
-302,188
-376,746
-333,814
Interest expense
30,460
23,491
16,547
13,183
Total other income/expenses net
-28,662
-37,063
-2,475
-20,404
Income before tax
-299,641
-369,759
-398,626
-367,401
Income tax expense
-550
-547
1,798
608
Income from continuing operations
-299,091
-369,212
-400,424
-368,009
Net income
-299,091
-369,212
-400,424
-368,009
Net income available to common shareholders
-299,091
-369,212
-400,424
-368,009
Basic EPS
-
-4.38
-7.43
-7.07
Diluted EPS
-
-4.38
-7.43
-7.07
Basic average shares
-
84,307
53,873
52,066
Diluted average shares
-
84,307
53,873
52,066
EBITDA
-
-338,070
-374,311
-349,617